![Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12884-022-05191-z/MediaObjects/12884_2022_5191_Fig1_HTML.png)
Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text
![Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356520312817-fx1.jpg)
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis - ScienceDirect
![The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases - European Medical Journal The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2021/11/Table-1-Recommendations-of-anti-rheumatic-medications-in-females-during....jpg)
The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases - European Medical Journal
![Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12884-022-05191-z/MediaObjects/12884_2022_5191_Fig3_HTML.png)
Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis | BMC Pregnancy and Childbirth | Full Text
![Frontiers | Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road Frontiers | Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road](https://www.frontiersin.org/files/Articles/621247/fphar-12-621247-HTML-r1/image_m/fphar-12-621247-g001.jpg)